Clinical Trial

Dynamical Electrophysiology and Neuropathology in Lewy's Bodies Disease

Study acronym: DYNAPATH-LB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Lewy body disease (LBD) is a neurodegenerative disorder that causes cognitive and behavioral problems. However, it is difficult to diagnose, and its pathophysiology is still not fully understood. The usual diagnostic criteria for LBD have excellent specificity but poor sensitivity. In particular, we lack paraclinical tests that can make a significant contribution. LBD patients may exhibit abnormalities in brain activity dynamics, which can be detected by EEG and may be linked to neuronal dysfunctions specific to the disease. The objective of this study is twofold: first, to assess the validity of this observation, that is, to confirm that the observed phenomenon is indeed linked to the pathophysiology of LBD, and second, to clarify the nature of these abnormalities by exploring the brain dynamics of LBD patients in greater detail.
Trial Details
NCT Number NCT07335692
Lead Sponsor University Hospital, Strasbourg, France
Conditions Lewy Body Disease
Enrollment 40 participants
Start Date 2025-06-02
Primary Completion 2026-06 (estimated)
Study Completion 2026-06-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-13